Pharma phoenix: big failures light the way to change
This article was originally published in Scrip
Executive Summary
Two very big compounds fizzled this week. Both are vestiges of a hopefully passing pan-industry desire to ride its business model stubbornness into oblivion. But one wonders if the message is received.